Human Mammary Microvascular Endothelial Cells

Cat.No.: CSC-C8612W

Species: Human

Source: Breast

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C8612W
Description
Human Mammary Microvascular Endothelial Cells from Creative Bioarray are isolated from human breast tissue. Human Mammary Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately cryopreserved in vails. Each vial contains at least 0.5×10^6 cells per ml. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic beads pre-coated with secondary antibody.
Species
Human
Source
Breast
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Normal
Quality Control
Human Mammary Microvascular Endothelial Cells from Creative Bioarray display typical cobblestone with large dark nuclei appearance under light microscopy. Cells are tested for expression of endothelial cell marker using antibody, CD31 (Catalog No. 550389, BD; CD31/PECAM-1 PE-conjugated Antibody, Catalog No. FAB3567P, R&D) or VE-Cadherin (FITC-VE-cadherin Catalog No. 560411, BD) by immunofluorescence staining or FACS. All cells test negative for mycoplasma, bacteria, yeast, and fungi. HIV-1, hepatitis B and hepatitis C are not detected for all donors and/or cell lots. Per request, a Certificate of Analysis will be provided for each cell lot purchased. Cells can be expanded for 3-5 passages under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human Mammary Microvascular Endothelial Cells (HMEC) are primary cells obtained from the microvascular endothelial layer of mammary gland. They constitute the inner lining of tiny blood arteries in breast tissue and are important for vascular homeostasis, nutrition exchange, and immune cell trafficking. In culture, HMEC form a typical cobblestone-like monolayer at confluence and require a specialized basal media supplemented with growth factors (e.g., VEGF) and serum to maintain their quiescent, differentiated phenotype. Standard cultivation conditions are 37 °C and 5 % CO2.

HMEC are a physiologically appropriate model for the study of mammary gland angiogenesis, vascular permeability and tumor microenvironment interactions. HMEC enable extravasation and spread of cancer cells in breast cancer. They are also utilized to study endothelial responses to hormones, cytokines and anti-angiogenic treatments, giving us insight into normal breast biology and pathological vascular remodeling.

SC Rescued TNFΑ-Induced Endothelial Barrier Dysfunction and Transendothelial Migration in TNBC In Vitro

Triple-negative breast cancer (TNBC) metastasis is exacerbated by tumor-associated vascular abnormalities. While Scutellarin (SC) is known for cardiovascular benefits, its role in mitigating TNBC metastasis via vascular protection is unknown. Mei's team investigated SC's ability to preserve endothelial barrier integrity against inflammatory insults.

TNFα and TGFβ disrupted endothelial tight junctions, decreasing VE-cadherin, occludin, and CD31 expression in HMMECs and HUVECs (Fig. 1a). SC treatment (5-20 µM) reversed this effect, restoring the expression of these junctional proteins (Fig. 1b, c). Functionally, SC rescued the TNFα-induced drop in transepithelial electrical resistance (TEER) (Fig. 1d) and attenuated FITC-dextran leakage (Fig.1e). Crucially, SC suppressed the transendothelial migration of MDA-MB-231 and 4T1 breast cancer cells across TNFα-stimulated endothelial monolayers (Fig. 1f). These data demonstrate that SC fortifies the endothelial barrier, thereby inhibiting tumor cell extravasation.

SC rescued the TNFα-induced endothelial barrier dysfunction in vitro.

Fig. 1. SC rescued the TNFα-induced endothelial barrier dysfunction in vitro (Mei X, Zhang J, et al., 2022).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products